Internal Medicine · Jeffersonville, IN
NPI
1043216971
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
443 Spring St Ste 200
Jeffersonville, IN, 47130
Phone (812) 288-8360
Groups this clinician bills Medicare through
Medicare paid, 2024
$381K
6,632 services
Medicare patients, 2024
1,145
Average age 74
Drug cost, 2024
$2.7M
46,833 prescriptions
Company payments, 2025
$1,052
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad I Masroor was code 99490 (chronic, principal, and transitional care management), 2,722 times for 367 patients. In total Muhammad I Masroor billed 6,632 services in 54 codes, and Medicare paid $381K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-20.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,722 | 367 | $45.06 | $123K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 993 | 302 | $35.67 | $35K |
| 99232 Hospital E&M - Subsequent | Facility | 751 | 277 | $57.82 | $43K |
| 99223 Hospital E&M - Initial | Facility | 306 | 276 | $126.90 | $39K |
| 99233 Hospital E&M - Subsequent | Facility | 278 | 184 | $86.80 | $24K |
| 99239 Hospital Discharge Management | Facility | 200 | 185 | $84.23 | $17K |
| 99308 SNF E&M | Facility | 190 | 83 | $56.11 | $11K |
| 99231 Hospital E&M - Subsequent | Facility | 169 | 51 | $36.22 | $6,120 |
| 99214 Office E&M - Established | Office | 120 | 64 | $85.07 | $10K |
| 99306 SNF E&M | Facility | 100 | 93 | $137.74 | $14K |
| 99213 Office E&M - Established | Office | 95 | 60 | $58.35 | $5,543 |
| 99306 SNF E&M | Office | 91 | 87 | $137.91 | $13K |
| 99308 SNF E&M | Office | 51 | 33 | $55.19 | $2,815 |
| 99305 SNF E&M | Facility | 50 | 45 | $100.82 | $5,041 |
| 99305 SNF E&M | Office | 49 | 45 | $98.77 | $4,840 |
By year: 2022 $227K for 3,167 services; 2023 $659K for 9,585 services; 2024 $381K for 6,632 services.
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad I Masroor prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,968 prescriptions and refills. In total Muhammad I Masroor wrote 46,833 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,968 | 3,283 | 343 | $28K |
| Eliquis Apixaban | 1,964 | 1,974 | 169 | $514K |
| Potassium Chloride Generic | 1,484 | 1,518 | 199 | $24K |
| Omeprazole Generic | 1,417 | 1,477 | 168 | $12K |
| Amlodipine Besylate Generic | 1,344 | 1,458 | 167 | $8,608 |
| Furosemide Generic | 1,317 | 1,402 | 194 | $7,146 |
| Levothyroxine Sodium Generic | 1,290 | 1,377 | 174 | $14K |
| Sertraline Hcl Generic | 1,163 | 1,232 | 126 | $11K |
| Pantoprazole Sodium Generic | 1,044 | 1,117 | 164 | $16K |
| Mirtazapine Generic | 1,040 | 1,054 | 115 | $19K |
| Tamsulosin Hcl Generic | 949 | 1,041 | 113 | $12K |
| Carvedilol Generic | 889 | 966 | 97 | $6,294 |
| Divalproex Sodium Generic | 887 | 887 | 85 | $30K |
| Trazodone Hcl Generic | 856 | 909 | 107 | $7,108 |
| Gabapentin Generic | 825 | 896 | 142 | $12K |
Brand drugs: 6,498 claims; generic drugs: 40,204 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad I Masroor $1,052 ($1,052 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $390.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 10 | $390 |
| Viatris Specialty LLC | 4 | $95.98 |
| Abbvie Inc. ABBV | 4 | $74.69 |
| Amgen Inc. AMGN | 4 | $59.19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $57.64 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $55.6 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43.14 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $42.4 |
| GlaxoSmithKline, LLC. GSK | 2 | $38.06 |
| Alkermes, Inc. ALKS | 2 | $32.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.